New prostate cancer guidelines: what they mean for you
Australia has just updated its prostate cancer early detection guidelines
Australia has just updated its prostate cancer early detection guidelines — for the first time in a decade. Here's what's changed, and what it might mean for you.
Australia has just updated its prostate cancer early detection guidelines - for the first time in a decade. Here's what's changed, and what it might mean for you.
If you've ever wondered whether you should get checked for prostate cancer – and at what age – you finally have a clearer answer.
The 2026 Clinical Practice Guidelines for the Early Detection of Prostate Cancer in Australia have just been released, replacing guidance that's been sitting untouched for ten years. They were developed by the Prostate Cancer Foundation of Australia and approved by the National Health and Medical Research Council, and they put Australia among the first countries in the world to take a modern, risk-based approach to finding prostate cancer early.
Movember has welcomed the change.
Why this matters:
Prostate cancer is the most commonly diagnosed cancer in Australia. 1 in 5 men here will be diagnosed in their lifetime. Around 29,000 men are diagnosed every year, and about 4,000 die from it.
Some men carry more risk than others. If prostate cancer runs in your family, your risk of being diagnosed is double that of other men. And if you live in regional or remote Australia, your risk of dying from the disease is 24 per cent higher.
So when should you get tested?
The new guidelines recommend that men over 50 speak to a doctor about prostate cancer testing.
If you're at higher risk, that drops to age 45. You're considered higher risk if:
- Prostate cancer runs in your family.
- You're a Black male with sub-Saharan African ancestry.
- You carry certain genetic mutations.
From age 45, if you're interested in your prostate health, you can talk to your GP about starting testing — even if you don't have a family history.
What else is new:
The guidelines also update how testing and diagnosis actually work. They cover risk assessment, shared decision-making with your GP, PSA testing, and the latest diagnostic pathways — including routinely using an MRI scan (multi-parametric MRI) before a biopsy. In plain terms: fewer men going through tests and treatments they may not need.
What Movember says:
Sam McKeown, Director of Prostate Cancer Research at Movember, called the Guidelines a fantastic step forward that will undoubtedly change lives.
“For a decade, the science moved forward while the clear guidance available to men and their GPs stood still. That gap has now closed."
“For the first time in Australia we have a contemporary framework built on the best available evidence, designed to encourage shared decision making between the man and his GP, and a risk adapted screening pathway. This will enable us to diagnose prostate cancer earlier while sparing men the tests and treatments they never needed. Understanding their prostate cancer risk will encourage more men to visit the GP and start having the conversation around prostate cancer screening.”
“The task now is implementation. Every man, in every postcode, deserves to understand his own risk and to feel confident raising it with his GP. Movember will keep investing in the research, programs and awareness that turn this evidence into fewer deaths and better lives for men.”
Your next step:
Know your risk. Then talk to your GP about it. That conversation is the whole point of these guidelines — and it's a lot easier to have now that everyone's working from the same, up-to-date information.
Sources:
- 2026 Clinical Practice Guidelines for the Early Detection of Prostate Cancer in Australia, Prostate Cancer Foundation of Australia (full Guidelines and summary of recommendations): pcfa.org.au
- Most commonly diagnosed cancer; 30 per cent of male cancer diagnoses; an estimated 29,000 cases and 4,000 deaths; 1 in 5 men in their lifetime (2025 estimates): AIHW (2026) Cancer data in Australia, Overview of cancer in Australia — aihw.gov.au
- Survival, mortality rate trend and 2035 incidence projection: AIHW (2026) Cancer data in Australia, as above, and Cancer data commentary 9: Prostate cancer — projection method changes — aihw.gov.au
- Family history doubles risk of diagnosis: PCFA, Risk factors — prostate.org.au
- 24 per cent higher risk of death for men in regional and remote Australia: PCFA, New data: Men in the regions face higher risk of harm due to prostate cancer — pcfa.org.au
